Troels is an Australian and Danish citizen, with a Medical Degree and PhD from Aarhus University, Denmark, with a past special academic interest in Diabetes, Endocrinology, and Hepatology, but with 21 years of broad industry experience across therapeutic areas.

Troels has a proven track record in developing and managing high-performing teams, external relationship creation and management, and identifying and developing the synergies between patient and business outcomes, all to the overall benefit of both patients, physicians and healthcare systems. He possesses superior both technical medical/scientific, organizational and people management skills and has worked in both Local, Regional and Global roles and functions within industry. Similarly, he has worked across a broad spectrum of country archetypes, including working across the Asia Pacific, China, India & Japan geographies, Europe and the US, propelling organizations into excellence by means of a crisp focus on driving patient outcomes, scientific excellence, digitalization and a strong emphasis on people & culture.

He currently is the Executive Medical Director for Amgen Australia.

Peter Rutherford is Global Medical Lead for Renal Rare Disease at Vifor Pharma in Zurich, CH. He qualified in Medicine at the University of Newcastle upon Tyne, UK and completed postgraduate medical training to obtain MRCP in 1989. He entered an academic training pathway in Nephrology with an MRC Training Fellowship allowing him to complete a PhD in cell physiology as well as completing clinical training in Nephrology and Internal Medicine. He was then an MRC Travelling Fellow at Yale University School of Medicine gaining additional academic experience in molecular biology.
After return to the UK as Lecturer in Medicine at the Unversity of Newcastle, he was appointed as Senior Lecturer in Nephrology at the University of Wales College of Medicine and Consultant Nephrologist. In this role, he combined clinical practice in delivering a full range of nephrology services with academic work. Peter then developed expertise as a clinical leader in the hospital and became the Medical Director of a combined acute, community and mental health NHS organization leading on patient safety, clinical effectiveness, service improvement and research. In addition he was a Clinical advisor at NICE and chaired their Guidelines Review Panel until he joined Pharma in 2007.
From 2007 to 2015 he was Medical Director Renal for Europe, Middle East and Africa at Baxter Healthcare – being responsible for all aspects of Medical Affairs activities across the region. He worked on research projects in patient support, decision making and education as well as new product development for home dialysis. From 2015 to 2017 he was Head of Integrated Market Access at Quintiles in Europe and Emerging Markets – supporting small and large Pharma and emerging biotech companies with medical affairs, medical communications, market access and patient centric services. Focused on launch brands, Peter support a range of companies across a range of therapeutic areas. Since joining Vifor Pharma, he is back on home ground in Nephrology but working in systemic diseases affecting every organ system.